Spearhead Bio
PrivateLast Round
Seed Round
Jun 18, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Spearhead Bio operates in Healthcare & Life Sciences and is based in St. Louis, Missouri. Its latest recorded funding round was a VC Round in January 2026.
Spearhead Bio is an agricultural biotechnology company that leads the next generation of native genome engineering tools to accelerate the development and launch of new transgenic & non-transgenic crops.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Spearhead Bio Comparables
Compare Spearhead Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Solis Agrosciences | 83% | |
| Demeetra AgBio | 78% | |
| Hudson River Biotechnology | 76% |
For institutional investors. Book with your work email.
Spearhead Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jun 18, 2026 | ||||
| VC Round | Jan 29, 2026 | ||||
| Grant | Jul 14, 2025 | ||||
| Seed | May 13, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Spearhead Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Danforth Technology Company | VC Round, Seed |
| BioGenerator Ventures | VC Round, Seed |
| Helix Fund | Seed |
| National Science Foundation | VC Round, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
$1.2M raised in Seed Round.
- Jan 29, 2026
$4M raised from BioGenerator Ventures and others.
For institutional investors. Book with your work email.
Spearhead Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Spearhead Bio's valuation, stock price, and market status.
Is Spearhead Bio a public or private company?
Spearhead Bio is a private company.
What is the current stock price of Spearhead Bio?
Spearhead Bio is a private company, so its shares have no public market price. Caplight tracks Spearhead Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Spearhead Bio worth (valuation)?
Valuation information for Spearhead Bio is not publicly available.
Can I buy Spearhead Bio stock?
Spearhead Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Spearhead Bio's last funding round?
Spearhead Bio's most recent funding round was Seed Round on June 18, 2026.
Who are the main investors in Spearhead Bio?
Key investors in Spearhead Bio include Danforth Technology Company.
Will Spearhead Bio IPO soon?
No public IPO plans have been announced for Spearhead Bio.
How can I track Spearhead Bio secondary market activity?
Caplight tracks bids, offers, and trades in Spearhead Bio's shares on secondary markets.